FDA Inspection
Jazz Pharmaceuticals, IncJazz Pharmaceuticals, Inc – FDA Inspection, May 30, 2012
Record Details
This FDA Inspection record concerns Jazz Pharmaceuticals, Inc, with an inspection on May 30, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Jazz Pharmaceuticals, Inc
- Inspection Date
- May 30, 2012
- Product Type
- Drugs
View Company Profile
ID · 8c19371d-931a-40ce-8436-b68d18f2718c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 780816
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 314.80(b)Failure to review ADE information
- 21 CFR 314.80(c)(1)(ii)Failure to investigate serious, unexpected events
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Jazz Pharmaceuticals, Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2019 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 10, 2017 | Not classified | San Francisco District Office | |
| July 20, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 4, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Jazz Pharmaceuticals, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.